Skip to main content

PolyPid Ltd 6-K, filed Oct 28, 2026

PolyPid Ltd. (PYPD)

6-K 2026-10-28 For: 2026-10-28
View Original
Added on October 28, 2026

About this 6-K

PolyPid Ltd filed this 6-K on October 28, 2026.

PolyPid introduced PD01B, a Kynatrix-based doxycycline candidate for diabetic foot infections, targeting a pre-IND meeting and first-in-human study in the second half of 2027. D-PLEX₁₀₀ is under FDA Priority Review with a November 28, 2026 PDUFA goal date. AI summary